文献速递细菌感染、耐药与抗菌药物

金黄色葡萄球菌疫苗诱导致死性CD4 T细胞反应

Lethal CD4 T Cell Responses Induced by Vaccination Against Staphylococcus aureus Bacteremia.
PubMed 文献 · J Infect Dis · 2017-01-01

针对金黄色葡萄球菌感染的候选疫苗临床试验屡遭失败,一项提前终止的试验显示术后感染接种者死亡率升高。本研究以辐照灭活金黄色葡萄球菌为多组分疫苗模型,发现接种小鼠在菌血症攻击后生存率下降,该有害效应由CD4 T细胞依赖性干扰素γ反应介导,并可通过在接种期间抑制该反应来预防。

要点

  • 多组分金黄色葡萄球菌疫苗模型可诱导CD4 T细胞依赖性IFN-γ反应。
  • 该反应导致菌血症攻击模型中小鼠生存率下降。
  • 接种期间抑制该反应可预防有害效应。

核心结论

  • 接种金黄色葡萄球菌多组分疫苗模型可诱导CD4 T细胞依赖性IFN-γ反应,导致菌血症攻击后小鼠生存率下降。

研究设计与样本

  • 研究使用致死性辐照的金黄色葡萄球菌作为多组分疫苗模型,对小鼠进行接种后行菌血症攻击。

主要发现

  • 接种小鼠在菌血症攻击模型中生存率下降。
  • 有害效应由CD4 T细胞依赖性干扰素γ反应介导。
  • 在接种期间抑制该反应可预防有害效应。

临床怎么用

  • 提示金黄色葡萄球菌疫苗设计需评估并避免诱导病理性CD4 T细胞/IFN-γ反应。
  • 未来疫苗开发应关注免疫保护与免疫病理的平衡。

局限性

  • 研究为小鼠模型,使用辐照灭活全菌作为疫苗模型,结果外推至人体需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multiple candidate vaccines against Staphylococcus aureus infections have failed in clinical trials. Analysis of a recent prematurely halted vaccine trial revealed increased mortality rates among vaccine recipients in whom postsurgical S. aureus infection developed, emphasizing the potential for induction of detrimental immune responses and the need to better understand the requirements for protective immunity against S. aureus. These failures of single-antigen vaccines have prompted ongoing development of multicomponent vaccines to target the multitude of S. aureus virulence factors. In the current study, we used lethally irradiated S. aureus as a model multicomponent vaccine and showed that vaccination of mice decreased survival in a bacteremia challenge model. These deleterious effects were due to a CD4 T-cell-dependent interferon γ response and could be prevented by inhibiting development of this response during vaccination. Our results identify the potential for vaccination to induce pathological immune responses, and they have implications for recent vaccine failures and the design of future staphylococcal vaccines.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Karauzum H, Haudenschild CC, Moore IN, et al. Lethal CD4 T Cell Responses Induced by Vaccination Against Staphylococcus aureus Bacteremia. J Infect Dis. 2017. PMID: 28329242. doi:10.1093/infdis/jix096

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。